FDA finalized Tuesday (Jun 12) two guidances clarifying FDA's rules for communicating health care economic information with payers and for promoting information that is consistent with, but absent from, a product's label. The agency answered calls from industry to broaden the scope of the HCEI guidance, and one stakeholder noted that the consistent-with-labeling guidance "establishes brighter lines than the draft." HHS Secretary Alex Azar and FDA Commissioner Scott Gottlieb say these guidances will help achieve the administration's plan of encouraging...